INSUGRO (IGF-1 LR3)

Contents Vial: IGF1(Insulin-Like Growth Factor1) Long R3 100mcg. Ampule: 2ml Sterile water for injection.
Administration Intramuscular injection.
Storage Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution.
Dosage Initial: .5 mcg/kg/day. May increase dose gradually. Max: 5 mcg/kg/day. Maximum period for administration 45 days.
Contraindications Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment.
Special Precautions Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis.
Adverse Drug Reactions Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching.
Drug Interactions High doses of corticosteroid may inhibit growth-promoting effects of IGF1LR3.
Disclaimer "Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice."